| abstract |
The present invention relates to aminoisoquinoline derivatives represented by the following formulas (I and II), homologues thereof or pharmaceutically acceptable salts thereof. Due to the excellent inhibitory effect on activated coagulation factor X, the compounds are useful as active ingredients in anticoagulants or in the prophylaxis and treatment of thrombus or embolism. |